Home Applications 021937 Application 021937
Type NDA
Sponsor GILEAD SCIENCES Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ATRIPLA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL 600MG;200MG;300MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021937-001 ATRIPLA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 600MG;200MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2006-07-12
Orange Book patents# Current patent rows page 1 of 1 · 5 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N021937-001 9018192 2026-06-13 U-1170 2015-05-28 N021937-001 9018192 2026-06-13 U-750 2015-05-28 N021937-001 9545414 2026-06-13 U-1170 Drug product 2017-02-13 N021937-001 9545414 2026-06-13 U-750 Drug product 2017-02-13 N021937-001 8598185 2029-04-28 Drug product
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021937-001 ATRIPLA 600MG;200MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2006-07-12 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL RLD 2006-07-12 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL RLD 2006-07-12 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL RLD 2006-07-12 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL RLD 2006-07-12 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL RLD 2006-07-12 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL RLD 2006-07-12 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL RLD 2006-07-12 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL RLD 2006-07-12 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N021937-001 ATRIPLA 600MG;200MG;300MG TABLET / ORAL AB RLD, RS 2006-07-12 cb3db0bc1861…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 11 · 419 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021937-001 9018192 2026-06-13 U-750 2015-05-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021937-001 9018192 2026-06-13 U-1170 2015-05-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021937-001 9545414 2026-06-13 U-1170 Drug product 2017-02-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021937-001 9545414 2026-06-13 U-750 Drug product 2017-02-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021937-001 8598185 2029-04-28 Drug product 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021937-001 9018192 2026-06-13 U-750 2015-05-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021937-001 9018192 2026-06-13 U-1170 2015-05-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021937-001 9545414 2026-06-13 U-1170 Drug product 2017-02-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021937-001 9545414 2026-06-13 U-750 Drug product 2017-02-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021937-001 8598185 2029-04-28 Drug product 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021937-001 9018192 2026-06-13 U-750 2015-05-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021937-001 9018192 2026-06-13 U-1170 2015-05-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021937-001 9545414 2026-06-13 U-1170 Drug product 2017-02-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021937-001 9545414 2026-06-13 U-750 Drug product 2017-02-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021937-001 8598185 2029-04-28 Drug product 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021937-001 9018192 2026-06-13 U-750 2015-05-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021937-001 9018192 2026-06-13 U-1170 2015-05-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021937-001 9545414 2026-06-13 U-1170 Drug product 2017-02-13 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021937-001 9545414 2026-06-13 U-750 Drug product 2017-02-13 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021937-001 8598185 2029-04-28 Drug product fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021937-001 9018192 2026-06-13 U-750 2015-05-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021937-001 9018192 2026-06-13 U-1170 2015-05-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021937-001 9545414 2026-06-13 U-1170 Drug product 2017-02-13 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021937-001 9545414 2026-06-13 U-750 Drug product 2017-02-13 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021937-001 8598185 2029-04-28 Drug product b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021937-001 8592397 2024-01-13 U-1170 Drug product 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021937-001 8592397 2024-01-13 U-750 Drug product 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021937-001 8716264 2024-01-13 U-257 Drug product 2014-05-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021937-001 9457036 2024-01-13 U-257 Drug product 2016-11-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021937-001 9744181 2024-01-13 U-257 Drug product 2017-09-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021937-001 9018192 2026-06-13 U-750 2015-05-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021937-001 9018192 2026-06-13 U-1170 2015-05-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021937-001 9545414 2026-06-13 U-1170 Drug product 2017-02-13 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021937-001 9545414 2026-06-13 U-750 Drug product 2017-02-13 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021937-001 8598185 2029-04-28 Drug product 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021937-001 8592397 2024-01-13 U-1170 Drug product 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021937-001 8592397 2024-01-13 U-750 Drug product 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021937-001 8716264 2024-01-13 U-257 Drug product 2014-05-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021937-001 9457036 2024-01-13 U-257 Drug product 2016-11-10 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021937-001 9744181 2024-01-13 U-257 Drug product 2017-09-19 2680178bc6a6…
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 13 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 15584-0101 Atripla efavirenz, emtricitabine, and tenofovir disoproxil fumarate Gilead Sciences, LLC NDA Current 15584-0101 Atripla efavirenz, emtricitabine, and tenofovir disoproxil fumarate Gilead Sciences, LLC NDA Current 15584-0101 Atripla efavirenz, emtricitabine, and tenofovir disoproxil fumarate Gilead Sciences, LLC NDA Current 15584-0101 Atripla efavirenz, emtricitabine, and tenofovir disoproxil fumarate Gilead Sciences, LLC NDA Current 15584-0101 Atripla efavirenz, emtricitabine, and tenofovir disoproxil fumarate Gilead Sciences, LLC NDA Current 50090-0980 Atripla efavirenz, emtricitabine, and tenofovir disoproxil fumarate A-S Medication Solutions NDA Current 53808-0208 Atripla efavirenz, emtricitabine, and tenofovir disoproxil fumarate DOH CENTRAL PHARMACY NDA Current 70518-0341 Atripla efavirenz, emtricitabine, and tenofovir disoproxil fumarate REMEDYREPACK INC. NDA Current 70518-0341 Atripla efavirenz, emtricitabine, and tenofovir disoproxil fumarate REMEDYREPACK INC. NDA Current 70518-0341 Atripla efavirenz, emtricitabine, and tenofovir disoproxil fumarate REMEDYREPACK INC. NDA Current 70518-0341 Atripla efavirenz, emtricitabine, and tenofovir disoproxil fumarate REMEDYREPACK INC. NDA Current 70518-0341 Atripla efavirenz, emtricitabine, and tenofovir disoproxil fumarate REMEDYREPACK INC. NDA Current 70518-0341 Atripla efavirenz, emtricitabine, and tenofovir disoproxil fumarate REMEDYREPACK INC. NDA Current